Federated Hermes
SLDB icon

Federated Hermes’s Solid Biosciences SLDB Stock Holding History

Federated Hermes’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,395
Closed -$8.86K – 2177
2025
Q1 		$8.86K Buy
+2,395
New +$10.3K ﹤0.01% 1826
2021
Q2 		– Sell
-374
Closed -$31K – 2323
2021
Q1 		$31K Buy
+374
New +$41.4K ﹤0.01% 1915
2020
Q4 		– Sell
-8
Closed -$1K – 2319
2020
Q3 		$1K Buy
+8
New +$306 ﹤0.01% 2189
2020
Q1 		– Sell
-7
Closed -$1K – 2348
2019
Q4 		$1K Buy
+7
New +$772 ﹤0.01% 2134

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Federated Hermes's SLDB Position: Q2 2025 in Review

Federated Hermes sold out of Solid Biosciences (SLDB) in Q2 2025, closing a stake of 2,395 shares — an estimated $8.86K sold.

Federated Hermes first reported a position in SLDB in Q4 2019 and held it in 4 quarters. The position peaked at $31K in Q1 2021. 114 funds tracked by Wall St. Rank hold SLDB as of Q2 2025.

  • Federated Hermes reported no remaining Solid Biosciences position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 2,395 Solid Biosciences shares in Q2 2025, an estimated $8.86K.
  • Federated Hermes first reported a position in Solid Biosciences in Q4 2019 and held it in 4 quarters.
  • Federated Hermes's Solid Biosciences position peaked at $31K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.